By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
Over the last 12 months, two Faeth Therapeutics, Inc. officers and board members picked up shares at market prices, about $1.2 million in total, and none of them sold.
The largest purchase came from STEPHENSON BRIAN C (CFO), about $165,000. Notably, at least one C-suite executive was among the buyers.
Big money check: 45 institutions held FTH as of Q2 2026, and more funds bought than sold. Quarter by quarter: 2 quarters in a row of net buying by insiders. Insiders bought in 2 of the last 7 full quarters.
Are insiders buying or selling FTH stock?
In the last 12 months Faeth Therapeutics, Inc. insiders made open-market purchases worth about $1.2 million and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in FTH?
The most recent open-market insider trade in FTH was filed on 2026-07-01.
How many institutions own FTH?
45 investment managers reported holding FTH in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded FTH?
No congressional trades in FTH were reported in the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).